An International, Observational Study to Define Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Acronyms INTEREST IN CD1
- Sponsors Ipsen
- 22 May 2019 Results assessing economic evaluation of abobotulinumtoxinA vs onabotulinumtoxinA by using data from this study presented at the 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
- 28 Nov 2018 New trial record
- 09 Oct 2018 Results from INTEREST IN CD1 [NCT00833196] INTER- EST IN CD2 [NCT01753349] and ANCHOR-CD [NCT01314365] describing the use of injection guidance (at baseline/ first injection visit and at 1 year) in 585 subjects, presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders.